Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BioStock: Lipum reports Q2 and increases the pace

In the report for the second quarter, biopharmaceutical company Lipum announces that they are increasing the pace of development of SOL-116 for rheumatoid arthritis. The clinical phase I study with the candidate is progressing according to plan and the company has identified a possibility to accelerate the second part of the study. With financial resources in place, the company looks forward to reporting results from the study in early 2024.Read the full article at biostock.se: https://www.biostock.se/en/2023/09/lipum-reports-q2-and-increases-the-pace/ This is a press release from

Hemsö’s shareholders make an equity injection of SEK 1.0 billion

Hemsö’s shareholders have decided to make an equity injection of SEK 1.0 billion to strengthen the capital structure and to finance Hemsö’s investments in new sustainable schools and nursing homes. The capital will be injected during the third quarter of 2023.“A stronger capital structure and liquidity position enables Hemsö to continue to support the public sector in times of growing need for new social infrastructure. With this year’s capital injection Hemsö’s owners have since 2019 provided equity of SEK 4.0 billion which has enabled investments in mainly new development of schools and

Case Study Snippets

Fenris the Cocker Spaniel defies death after licking jellyfish Swift vet action saved the day as UK family warns other pet owners about beach safety.   During a stroll in Colwyn Bay, Fenris the 11-month-old Cocker Spaniel encountered a Lion's Mane jellyfish. The happy-go-lucky pup licked the jellyfish, immediately causing vomiting and distress. In a  desperate state, Fenris ingested sand and sea water.   Recognising the urgency, her owner rushed her to a nearby weekend vet. Acting swiftly, the vet administered antihistamines and opioids to counter venom effects. A 20-minute

Love for Luna – Top Puppy Names by Breed!

Agria Pet Insurance reveals the 2023 puppy names that have taken the UK by storm.Finding the perfect name for your puppy can be an exciting but tough task. Whether you're drawn to a sentimental name or want to pick the cutest name for your adorable pooch, it's helpful to know the trendiest names for your furry companion. Keep in mind that these popular names can evolve over time, so it's vital to stay in the loop!   Luna reigned supreme as the top name amongst the majority of dog breeds, closely followed by Teddy and Poppy.   One of the world’s leading animal insurers - Agria

Arctic Paper moves to Warsaw Stock Exchange mWIG40 index

Arctic Paper S.A. announces that from September 1, 2023, the company's shares will be traded on Warsaw Stock Exchange mWIG40 index. mWIG40 index is successor of MIDWIG index and has been calculated since December 31, 1997 and comprises 40 medium size companies listed at WSE Main List. mWIG40 is a price index and thus when it is calculated it accounts only for prices of underlying shares whereas dividend income is excluded."The move of our stock to the mWIG40 index confirms that the course of development of Arctic Paper is correct. It is also a proof that our position on the capital market

BioStock: BioInvent soon has five drug candidates in six clinical studies

BioInvent has made several advances in the second quarter of 2023, in particular with its lead drug candidate BI-1206. In addition to a strengthened pipeline, the company’s Q2 report highlights progress across the broad portfolio of drug candidates in clinical development. In the report, CEO Martin Welschof reminds that BioInvent will soon have five drug candidates in six parallel patient studies.Read the article at biostock.se: https://www.biostock.se/en/2023/09/bioinvent-soon-has-five-drug-candidates-in-six-clinical-studies/ This is a press release from BioStock - Connecting

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 131 - 1 SEPTEMBER 2023   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 112/23 and 113/23.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Contract extension for CSV “Normand Superior”

Solstad Offshore is pleased to announce a contract extension for the CSV “Normand Superior” with Ocean Infinity AB. The contract is now firm until 1Q 2026, with two optional years thereafter. The commercial terms are in line with present market conditions for this type of vessel.  Skudeneshavn, 1st September 2023 ContactsLars Peder Solstad CEO, at +47 91 31 85 85Kjetil Ramstad CFO, at +47 90 75 94 89 Solstad Offshore ASA

SBTi approves Sandvik’s science-based emission reduction targets

Sandvik’s targets for reducing greenhouse gas (GHG) emissions have now been validated by the Science Based Targets initiative (SBTi) as aligned with the latest climate science and consistent with the goals of the Paris Agreement. Sandvik committed to set targets in line with SBTI’s criteria in December 2021 and submitted the new targets for validation in November 2022. With the new targets Sandvik commits to reach net-zero GHG emissions by 2050 at the latest. Sandvik also commits to reducing absolute scope 1 and 2 GHG emissions by 50% by 2030 with 2019 as the base year, and to reduce

Medivir Hosts Expert Perspectives Webcast on the Evolving Treatment Landscape and the Unique Treatment Challenges in HCC

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that it will host a key opinion leader webcast on the current and future HCC (primary liver cancer) treatment landscape, including how treatment challenges and needs in HCC differs from most other cancers. The webcast will take place on September 8, 2023 at 13:00 CET/07:00 EST. The webcast will feature presentations by Dr. Jeff Evans, Beatson West of Scotland Cancer Center, Glasgow, UK, who will

TARJA MYLÉN APPOINTED AS MANDATUM’S CHIEF AUDIT EXECUTIVE

Tarja Mylén has been appointed as Mandatum’s Chief Audit Executive, having previously acted in numerous positions over a long period of time within Sampo Group. Internal Audit is carried out independently of the company’s business operations. Its mandate is to objectively assess and ensure the organisation’s business activities. Mylén joins Mandatum from the position of Responsible Internal Auditor at Sampo Group. She began her career in Sampo in 1986 and moved to Internal Audit in 2001 after working with business operations for 15 years. Mylén has also acted as Chief Audit Executive for

Betolar Plc Management Team compresses

Betolar Plc Company Release  1 September 2023 at 9:30 AM EEST Betolar Plc Management Team compresses Janne Rauramo, Member of Betolar Plc’s Management Team and Executive Vice President Strategic Partnerships, has decided to leave the company. Rauramo’s employment will end on 30 November 2023, at the latest. Strategic partnerships will be part of the company’s commercial and operative activities. ”I warmly thank Janne for successfully leading strategic partnerships and for his strong contribution to Betolar during the past four years. I wish him the best of luck and success in

Shaping the evolution of flotation: Metso celebrates 50 years in mechanical flotation

Metso Corporation’s press release on September 1, 2023, at 09:00 a.m. EESTFlotation technology has played a pivotal role in Metso’s history for over five decades. Evolving from humble beginnings at Outokumpu, and then further developed by Outotec, Metso has shaped the course of mechanical flotation and propelled the industry forward. The OK cell was taken into commercial use in 1973 with a capacity of 16 cubic meters. At that time in flotation history, tanks were square-shaped when viewed from the top. As demand for even larger tanks escalated, a 38-cubic-meter version was introduced to

(Retransmission) AcuCort signs partnership agreement for the four major Nordic countries with Unimedic Pharma

Retransmission of the press release that was published, with the associated MAR label, on August 31, 2023, at 17:35 CET. AcuCort AB has today signed a partnership agreement for Sweden, Norway, Denmark and Finland with Unimedic Pharma. The agreement means that Unimedic will be responsible for sales and marketing of AcuCort's oral film Zeqmelit® in these countries.With the agreement, AcuCort enters the commercialization phase that the company has been preparing for a long time. Previously, the company's oral film Zeqmelit® has received approval from pharmaceutical authorities in Sweden,

United Bankers Plc: Notification of Manager’s Transactions – Paadla AS

United Bankers Plc STOCK EXCHANGE RELEASE 1 September 2023 at 9:00 EEST   United Bankers Plc: Notification of Manager’s Transactions – Paadla AS ____________________________________________ Person subject to the notification requirement Name: Paadla AS Position: Closely associated person (X) Legal person (1): Person Discharging Managerial Responsibilities In Issuer Name: Patrick Anderson Position: Chief Executive Officer Issuer: United Bankers Plc LEI: 743700J2WO3J6XGFPG77 Notification type: INITIAL NOTIFICATION Reference number: 37263/4/4 _______

STENOCARE’s commitment to supply medical cannabis to patients

STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER:  STENO STENOCARE A/S (“Stenocare”) is addressing the supply challenges faced by general medicine products in Europe, with a commitment to managing their supply chain to uphold the principle of providing ongoing and predictable treatment with Stenocare products.Doctors and patients often take for granted that prescription-based medicine will always be available for treatment. However, throughout 2023, a situation of growing supply challenges with various types of medicine has arisen in many European markets. In Denmark, the

Q3 2023: A profitable quarter with the highest passenger figure since before the pandemic

I am pleased to conclude a busy summer quarter. Almost 7 million passengers traveled with SAS during the third quarter, the highest quarterly passenger figure since before the pandemic. For the first time since 2019, we also posted a quarterly profit. This is an important milestone. We still have a lot of work ahead of us with our transformation to secure long-term competitiveness, but I consider this a clear sign that we are on the right track and that our efforts are paying off. We continue our ramp-up and will increase capacity this winter, compared to the same period last year. We also

Total Voting Rights

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION 1 September 2023 Redde Northgate plc - Total Voting Rights   The following notification is made in accordance with Rule 5.6 of the FCA's Disclosure Guidance and Transparency Rules. As at close of business on 31 August 2023, Redde Northgate PLC confirms that its share capital consists of 246,091,423 ordinary shares of 50p each, of which 17,477,571

Announcement from Systemair AB (publ) Annual General Meeting 2023

Press release, 1 September 2023 Systemair (NASDAQ OMX Stockholm: SYSR) held its Annual General Meeting on August 31, 2023 in the Systemair Expo in Skinnskatteberg, Sweden. At the meeting, 136 voting shareholders were present, alternatively submitted valid postal votes, which corresponds to 86,41 % of the total number of votes and shares. The Meeting voted in favour of the Board’s and the Nomination committee’s proposal in all suggestions. The main content of the most important decisions was:   Adoption of income statement and balance sheet, dividend and discharge from liability

Acquisition of commercial portfolio from Sønderjysk Forsikring completed

Reference is made to earlier announcement on Gjensidige’s agreement to acquire Sønderjysk Forsikring’s commercial portfolio, with premiums of approximately DKK 200 million. The transaction has been approved by the relevant authorities and is completed today. The purchase price is approximately DKK 200 million.  Contact persons Gjensidige Forsikring ASA:Head of Investor Relations: Mitra H. Negård, Tel: +47 957 93 631Head of Communication: Øystein Thoresen, Tel: + 47 952 33 382

Norwegian celebrates 20th jubilee since first flight from Stockholm Arlanda Airport

On the 1st of September 2003, the first ever flight with the airline Norwegian took place between Stockholm Arlanda Airport and Oslo Gardermoen. Twenty years on, Norwegian has served almost 65 000 000 passengers flying to and from Arlanda Airport, making their well know red nosed planes a familiar sight in the skies above the airport. It was on the 1[st] of September 2003 that Norwegian established itself firmly at Stockholm Arlanda Airport and twenty years on, they have safely seen close to a staggering 65 000 000 passengers to and from Arlanda making their red nosed airplanes a

Metso’s headquarters moves to Matinkylä, Espoo

Metso Corporation’s press release on September 1, 2023 at 08.50 a.m. EESTMetso moves its headquarters to Matinkylä, Espoo, in September 2023, and at the same time ends activities in the current headquarters in Sanomatalo, Helsinki. The address for Metso’s new headquarters is P.O. Box 1000, 02231 Espoo, and the visiting address Rauhalanpuisto 9, 02230 Espoo. Phone number for the switchboard is +358 20 484 100. The e-invoicing address for Metso Corporation remains unchanged: Basware Oyj BAWCFI22, 003708281054. The VAT/business registration number is FI08281054. Further information,

There are no items matching the current filter
There are no more items matching the current filter
Back to top